Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 241

1.

Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study.

Wunsch E, Raszeja-Wyszomirska J, Barbier O, Milkiewicz M, Krawczyk M, Milkiewicz P.

J Gastrointestin Liver Dis. 2018 Sep;27(3):273-279. doi: 10.15403/jgld.2014.1121.273.icz.

2.

Autoimmune hepatitis exerts a profound, negative effect on health related quality of life: a prospective, single centre study.

Janik MK, Wunsch E, Raszeja-Wyszomirska J, Moskwa M, Kruk B, Krawczyk M, Milkiewicz P.

Liver Int. 2018 Sep 11. doi: 10.1111/liv.13960. [Epub ahead of print]

PMID:
30204306
3.

PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.

Kruk B, Liebe R, Milkiewicz M, Wunsch E, Raszeja-Wyszomirska J, Lammert F, Milkiewicz P, Krawczyk M.

PLoS One. 2018 Aug 30;13(8):e0202942. doi: 10.1371/journal.pone.0202942. eCollection 2018.

4.

Urinary Elimination of Bile Acid Glucuronides under Severe Cholestatic Situations: Contribution of Hepatic and Renal Glucuronidation Reactions.

Perreault M, Wunsch E, Białek A, Trottier J, Verreault M, Caron P, Poirier GG, Milkiewicz P, Barbier O.

Can J Gastroenterol Hepatol. 2018 Apr 11;2018:8096314. doi: 10.1155/2018/8096314. eCollection 2018.

5.

Genetic Risk Factors for Autoimmune Thyroid Disease might Affect the Susceptibility to and Modulate the Progression of Primary Biliary Cholangitis.

Kuś A, Arłukowicz-Grabowska M, Szymański K, Wunsch E, Milkiewicz M, Płoski R, Shums Z, Norman GL, Milkiewicz P, Bednarczuk T, Krawczyk M.

J Gastrointestin Liver Dis. 2017 Sep;26(3):245-252. doi: 10.15403/jgld.2014.1121.263.kus.

6.

ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis.

Kempinska-Podhorodecka A, Milkiewicz M, Jabłonski D, Milkiewicz P, Wunsch E.

PLoS One. 2017 Apr 20;12(4):e0176264. doi: 10.1371/journal.pone.0176264. eCollection 2017.

7.

Polymorphisms of IL12RB2 May Affect the Natural History of Primary Biliary Cholangitis: A Single Centre Study.

Wasik U, Wunsch E, Norman GL, Rigopoulou EI, Bogdanos DP, Milkiewicz P, Milkiewicz M.

J Immunol Res. 2017;2017:2185083. doi: 10.1155/2017/2185083. Epub 2017 Feb 19.

8.

Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.

de Vries EMG, Färkkilä M, Milkiewicz P, Hov JR, Eksteen B, Thorburn D, Chazouillères O, Pares A, Nygård S, Gilja OH, Wunsch E, Invernizzi P, Carbone M, Bernuzzi F, Boberg KM, Røsjø H, Rosenberg W, Beuers UH, Ponsioen CY, Karlsen TH, Vesterhus M.

Liver Int. 2017 Oct;37(10):1554-1561. doi: 10.1111/liv.13402. Epub 2017 Apr 13.

PMID:
28267887
9.

The effect of short term treatment with probiotic VSL#3 on various clinical and biochemical parameters in patients with liver cirrhosis.

Marlicz W, Wunsch E, Mydlowska M, Milkiewicz M, Serwin K, Mularczyk M, Milkiewicz P, Raszeja-Wyszomirska J.

J Physiol Pharmacol. 2016 Dec;67(6):867-877.

10.

Population-based cost-offset analyses for disorder-specific treatment of anorexia nervosa and bulimia nervosa in Germany.

Bode K, Götz von Olenhusen NM, Wunsch EM, Kliem S, Kröger C.

Int J Eat Disord. 2017 Mar;50(3):239-249. doi: 10.1002/eat.22686. Epub 2017 Feb 2.

PMID:
28152200
11.

A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.

Paziewska A, Habior A, Rogowska A, Zych W, Goryca K, Karczmarski J, Dabrowska M, Ambrozkiewicz F, Walewska-Zielecka B, Krawczyk M, Cichoz-Lach H, Milkiewicz P, Kowalik A, Mucha K, Raczynska J, Musialik J, Boryczka G, Wasilewicz M, Ciecko-Michalska I, Ferenc M, Janiak M, Kanikowska A, Stankiewicz R, Hartleb M, Mach T, Grzymislawski M, Raszeja-Wyszomirska J, Wunsch E, Bobinski T, Mikula M, Ostrowski J.

BMC Med Genomics. 2017 Jan 6;10(1):2. doi: 10.1186/s12920-016-0239-9.

12.

Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis.

Milkiewicz M, Klak M, Kempinska-Podhorodecka A, Wiechowska-Kozlowska A, Urasinska E, Blatkiewicz M, Wunsch E, Elias E, Milkiewicz P.

Sci Rep. 2016 Dec 23;6:39573. doi: 10.1038/srep39573.

13.

Selective and sensitive quantification of the cytochrome P450 3A4 protein in human liver homogenates through multiple reaction monitoring mass spectrometry.

Cieślak A, Kelly I, Trottier J, Verreault M, Wunsch E, Milkiewicz P, Poirier G, Droit A, Barbier O.

Proteomics. 2016 Nov;16(21):2827-2837. doi: 10.1002/pmic.201500386. Epub 2016 Oct 10.

PMID:
27634100
14.

Plasmapheresis exerts a long-lasting antipruritic effect in severe cholestatic itch.

Krawczyk M, Liebe R, Wasilewicz M, Wunsch E, Raszeja-Wyszomirska J, Milkiewicz P.

Liver Int. 2017 May;37(5):743-747. doi: 10.1111/liv.13281. Epub 2016 Nov 17.

PMID:
27778443
15.

Serum Autotaxin is a Marker of the Severity of Liver Injury and Overall Survival in Patients with Cholestatic Liver Diseases.

Wunsch E, Krawczyk M, Milkiewicz M, Trottier J, Barbier O, Neurath MF, Lammert F, Kremer AE, Milkiewicz P.

Sci Rep. 2016 Aug 10;6:30847. doi: 10.1038/srep30847.

16.

[Interdisciplinary Care of Employees with Mental Disorders: A Fact Check Using the Salzgitter-Model as an Example].

Bode K, Wunsch EM, Finger F, Kröger C.

Psychother Psychosom Med Psychol. 2016 Jun;66(6):235-41. doi: 10.1055/s-0042-106728. Epub 2016 Jun 10. German.

PMID:
27286528
17.

Factors Affecting Exercise Test Performance in Patients After Liver Transplantation.

Kotarska K, Wunsch E, Jodko L, Raszeja-Wyszomirska J, Bania I, Lawniczak M, Bogdanos D, Kornacewicz-Jach Z, Milkiewicz P.

Hepat Mon. 2016 Mar 21;16(3):e34356. doi: 10.5812/hepatmon.34356. eCollection 2016 Mar.

18.

Assessment of health related quality of life in polish patients with primary biliary cirrhosis.

Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Kostrzewa K, Norman GL, Bogdanos DP, Milkiewicz P.

Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):471-9. doi: 10.1016/j.clinre.2015.10.006. Epub 2015 Nov 24.

PMID:
26621536
19.

Leisure time physical activity and health-related behaviours after liver transplantation: a prospective, single-centre study.

Kotarska K, Wunsch E, Raszeja-Wyszomirska J, Kempińska-Podhorodecka A, Wójcicki M, Milkiewicz P.

Prz Gastroenterol. 2015;10(2):100-4. doi: 10.5114/pg.2015.49002. Epub 2015 Feb 8.

20.

Liver Expression of Sulphotransferase 2A1 Enzyme Is Impaired in Patients with Primary Sclerosing Cholangitis: Lack of the Response to Enhanced Expression of PXR.

Wunsch E, Klak M, Wasik U, Milkiewicz M, Blatkiewicz M, Urasinska E, Barbier O, Bielicki D, Bogdanos DP, Elias E, Milkiewicz P.

J Immunol Res. 2015;2015:571353. doi: 10.1155/2015/571353. Epub 2015 Oct 4.

21.

Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.

Wunsch E, Milkiewicz M, Wasik U, Trottier J, Kempińska-Podhorodecka A, Elias E, Barbier O, Milkiewicz P.

Sci Rep. 2015 Aug 21;5:13462. doi: 10.1038/srep13462.

22.

Female Sex But Not Original Indication Affects Physical Activity After Liver Transplant: A Prospective, Single Center Study.

Kotarska K, Wunsch E, Raszeja-Wyszomirska J, Kempińska-Podhorodecka A, Wójcicki M, Milkiewicz P.

Exp Clin Transplant. 2015 Jun;13(3):243-6.

23.

Live birth after artificial oocyte activation using a ready-to-use ionophore: a prospective multicentre study.

Ebner T, Montag M; Oocyte Activation Study Group, Montag M, Van der Ven K, Van der Ven H, Ebner T, Shebl O, Oppelt P, Hirchenhain J, Krüssel J, Maxrath B, Gnoth C, Friol K, Tigges J, Wünsch E, Luckhaus J, Beerkotte A, Weiss D, Grunwald K, Struller D, Etien C.

Reprod Biomed Online. 2015 Apr;30(4):359-65. doi: 10.1016/j.rbmo.2014.11.012. Epub 2014 Dec 9.

PMID:
25596904
24.

Work-related treatment for major depressive disorder and incapacity to work: preliminary findings of a controlled, matched study.

Kröger C, Bode K, Wunsch EM, Kliem S, Grocholewski A, Finger F.

J Occup Health Psychol. 2015 Apr;20(2):248-58. doi: 10.1037/a0038341. Epub 2014 Nov 17.

PMID:
25402222
25.

Prospective evaluation of PBC-specific health-related quality of life questionnaires in patients with primary sclerosing cholangitis.

Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, Rigopoulou EI, Bogdanos D, Milkiewicz P.

Liver Int. 2015 Jun;35(6):1764-71. doi: 10.1111/liv.12730. Epub 2014 Dec 4.

PMID:
25388280
26.

Relationship between pretransplantation liver status and health-related quality of life after grafting: a single-center prospective study.

Kotarska K, Raszeja-Wyszomirska J, Wunsch E, Chmurowicz T, Kempińska-Podhorodecka A, Wójcicki M, Milkiewicz P.

Transplant Proc. 2014 Oct;46(8):2770-3. doi: 10.1016/j.transproceed.2014.09.005.

PMID:
25380914
27.

Variant adiponutrin confers genetic protection against cholestatic itch.

Krawczyk M, Milkiewicz M, Marschall HU, Bartz C, Grünhage F, Wunsch E, Milkiewicz P, Lammert F.

Sci Rep. 2014 Oct 9;4:6374. doi: 10.1038/srep06374.

28.

Population-based cost-offset estimation for the treatment of borderline personality disorder: projected costs in a currently running, ideal health system.

Wunsch EM, Kliem S, Kröger C.

Behav Res Ther. 2014 Sep;60:1-7. doi: 10.1016/j.brat.2014.06.002. Epub 2014 Jun 24.

PMID:
25014129
29.

Factors affecting health-related quality of life and physical activity after liver transplantation for autoimmune and nonautoimmune liver diseases: a prospective, single centre study.

Kotarska K, Wunsch E, Kempińska-Podhorodecka A, Raszeja-Wyszomirska J, Bogdanos DP, Wójcicki M, Milkiewicz P.

J Immunol Res. 2014;2014:738297. doi: 10.1155/2014/738297. Epub 2014 Mar 4.

30.

Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.

Wunsch E, Trottier J, Milkiewicz M, Raszeja-Wyszomirska J, Hirschfield GM, Barbier O, Milkiewicz P.

Hepatology. 2014 Sep;60(3):931-40. doi: 10.1002/hep.27074. Epub 2014 Jul 30.

PMID:
24519384
31.

In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy.

Wunsch E, Koziarska D, Milkiewicz M, Naprawa G, Nowacki P, Hartleb M, Milkiewicz P.

Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1402-7. doi: 10.1097/MEG.0b013e328365a447.

PMID:
24025977
32.

Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study.

Koziarska D, Wunsch E, Milkiewicz M, Wójcicki M, Nowacki P, Milkiewicz P.

BMC Gastroenterol. 2013 Jul 2;13:107. doi: 10.1186/1471-230X-13-107.

33.

TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.

Raszeja-Wyszomirska J, Wunsch E, Kempinska-Podhorodecka A, Smyk DS, Bogdanos DP, Milkiewicz M, Milkiewicz P.

Clin Dev Immunol. 2013;2013:510547. doi: 10.1155/2013/510547. Epub 2013 Apr 28.

34.

Normalization of the psychometric hepatic encephalopathy score in Polish population. A prospective, quantified electroencephalography study.

Wunsch E, Koziarska D, Kotarska K, Nowacki P, Milkiewicz P.

Liver Int. 2013 Oct;33(9):1332-40. doi: 10.1111/liv.12194. Epub 2013 May 8.

PMID:
23651263
35.

Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study.

Wunsch E, Naprawa G, Koziarska D, Milkiewicz M, Nowacki P, Milkiewicz P.

Ann Hepatol. 2013 May-Jun;12(3):448-55.

36.

TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis.

Kempinska-Podhorodecka A, Shums Z, Wasilewicz M, Wunsch E, Milkiewicz M, Bogdanos DP, Norman GL, Milkiewicz P.

Clin Dev Immunol. 2012;2012:487521. doi: 10.1155/2012/487521. Epub 2012 Oct 22.

37.

Vitamin d receptor polymorphisms predispose to primary biliary cirrhosis and severity of the disease in polish population.

Kempińska-Podhorecka A, Wunsch E, Jarowicz T, Raszeja-Wyszomirska J, Loniewska B, Kaczmarczyk M, Milkiewicz M, Milkiewicz P.

Gastroenterol Res Pract. 2012;2012:408723. doi: 10.1155/2012/408723. Epub 2012 May 29.

38.

Esophageal duplication cysts: endosonographic findings in asymptomatic patients.

Wiechowska-Kozłowska A, Wunsch E, Majewski M, Milkiewicz P.

World J Gastroenterol. 2012 Mar 21;18(11):1270-2. doi: 10.3748/wjg.v18.i11.1270.

39.

Liver transplantation in chronic cholestatic conditions.

Milkiewicz P, Wunsch E, Elias E.

Front Biosci (Landmark Ed). 2012 Jan 1;17:959-69. Review.

PMID:
22201783
40.

Primary sclerosing cholangitis.

Milkiewicz P, Wunsch E.

Recent Results Cancer Res. 2011;185:117-33. doi: 10.1007/978-3-642-03503-6_7. Review.

PMID:
21822823
41.

Minimal hepatic encephalopathy does not impair health-related quality of life in patients with cirrhosis: a prospective study.

Wunsch E, Szymanik B, Post M, Marlicz W, Mydłowska M, Milkiewicz P.

Liver Int. 2011 Aug;31(7):980-4. doi: 10.1111/j.1478-3231.2011.02465.x. Epub 2011 Feb 10.

PMID:
21733087
42.

[Probiotics in chronic liver diseases].

Wunsch E, Marlicz W, Milkiewicz P.

Pol Merkur Lekarski. 2010 Dec;29(174):390-4. Review. Polish.

PMID:
21298992
43.

Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis.

Wunsch E, Post M, Gutkowski K, Marlicz W, Szymanik B, Hartleb M, Milkiewicz P.

Dig Liver Dis. 2010 Nov;42(11):818-21. doi: 10.1016/j.dld.2010.03.017. Epub 2010 Apr 28.

PMID:
20430705
44.

Synthetic study on cystinyl peptides using solution and solid phase methodology: human IgG1 hinge region.

Niederhafner P, Gut V, Jezek J, Budesínský M, Kasicka V, Wünsch E, Hlavácek J.

Amino Acids. 2010 Aug;39(3):641-50. doi: 10.1007/s00726-010-0485-7. Epub 2010 Feb 19.

PMID:
20169376
45.

Modified Charlson Comorbidity Index in predicting early mortality after liver transplantation.

Wasilewicz M, Raszeja-Wyszomirska J, Wunsch E, Wójcicki M, Milkiewicz P.

Transplant Proc. 2009 Oct;41(8):3117-8. doi: 10.1016/j.transproceed.2009.07.097.

PMID:
19857690
46.

Assessment of a modified Child-Pugh-Turcotte score to predict early mortality after liver transplantation.

Raszeja-Wyszomirska J, Wasilewicz MP, Wunsch E, Szymanik B, Jarosz K, Wójcicki M, Milkiewicz P.

Transplant Proc. 2009 Oct;41(8):3114-6. doi: 10.1016/j.transproceed.2009.07.098.

PMID:
19857689
47.

Upper gastrointestinal endosonography in patients evaluated for liver transplantation.

Wiechowska-Kozlowska A, Raszeja-Wyszomirska J, Wasilewicz MP, Bialek A, Wunsch E, Wójcicki M, Milkiewicz P.

Transplant Proc. 2009 Oct;41(8):3082-4. doi: 10.1016/j.transproceed.2009.07.095.

PMID:
19857682
48.

The peptides of alpha-aminosuberic acid II. Synthesis of deamino-dicarba-eel-calcitonin sequence 1-9.

Gut V, Cerovský V, Zertová M, Körblová E, Malon P, Stocker H, Wünsch E.

Amino Acids. 2001;21(3):255-63.

PMID:
11764406
49.

Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols.

Neulen J, Wenzel D, Hornig C, Wünsch E, Weissenborn U, Grunwald K, Büttner R, Weich H.

Hum Reprod. 2001 Apr;16(4):621-6.

PMID:
11278207
50.

The peptides of alpha-aminosuberic acid I. New intermediates for synthetic studies.

Wünsch E, Stocker H, Malon P, Gut V, Cerovský V, Zertová M, Laffan DD.

Amino Acids. 2000;18(3):219-27.

PMID:
10901619

Supplemental Content

Loading ...
Support Center